FORSYTH DOUGLAS has filed 5 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 15000 shares of Inhibrx Biosciences, Inc. ($INBX) on May 28, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28, 2025 | Inhibrx Biosciences, Inc. | $INBX | FORSYTH DOUGLAS | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 14,476,000 | 9999.99% | 0.10% |
| Aug. 22, 2024 | Inhibrx Biosciences, Inc. | $INBX | FORSYTH DOUGLAS | Director | P | Common Stock | 15188 | $12.89 | 164,752.0000 | 14,476,000 | 10.15% | 0.10% |
| Aug. 23, 2024 | Inhibrx Biosciences, Inc. | $INBX | FORSYTH DOUGLAS | Director | P | Common Stock | 59812 | $14.07 | 224,564.0000 | 14,476,000 | 36.30% | 0.41% |
| May 29, 2024 | Inhibrx Biosciences, Inc. | $INBX | FORSYTH DOUGLAS | Director | A | Common Stock | 149564 | $0.00 | 149,564.0000 | 49,234,000 | 9999.99% | 0.30% |
| May 30, 2024 | Inhibrx Biosciences, Inc. | $INBX | FORSYTH DOUGLAS | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 14,475,904 | 9999.99% | 0.21% |